Using secondary fund share investments as a profit growth driver to optimize the investment portfolio, enhance short-to-medium-term returns, and accelerate cash flow recovery. Currently, the main S fund operations include a dedicated biopharmaceutical S fund and a dedicated integrated circuit S fund.